[Baiotai: notice of approval for New indications of BAT6026 injection] Science and Technology Innovation Board Daily reported on the 12th that it recently received a "notice of approval of Drug Clinical trial" approved and issued by the State Drug Administration, and the company's application for BAT6026 injection to carry out clinical trials of I/II in patients with atopic dermatitis was approved.